Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real value — or simply taking advantage of another food fad?

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...

Management outlined significant revenue contributions from TRYNGOLZA and donidalorsen in 2025. TRYNGOLZA is positioned to increase patient identification and diagnosis over time, with a gradual launch ...

Consequently, food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...

Antennas receive and transmit electromagnetic waves, delivering information to our radios, televisions, cellphones and more.

Eli Lilly 's blockbuster weight loss drugs, and questions about its valuation. Then, Ricky continues his conversation with ...

With a fresh year underway, many individuals are pursuing healthier lifestyles and setting new wellness goals. SynergenX Health highlights the importance of hormone testing as part of routine medical ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company, today announced that it has appointed Alex Rothwell as the Company's new Chief Financial Officer, ...

On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...

Most dietary programs are designed to help people achieve weight loss or adhere to U.S. nutrition guidelines, which currently ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...